成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

  1. Vitamin D Related/Nuclear Receptor Metabolic Enzyme/Protease
  2. Androgen Receptor Endogenous Metabolite
  3. DHEA

DHEA  (Synonyms: 脫氫表雄酮; Prasterone; Dehydroisoandrosterone; Dehydroepiandrosterone)

目錄號(hào): HY-14650 純度: 99.93%
COA 產(chǎn)品使用指南

DHEA (Prasterone) 是最豐富的類(lèi)固醇激素之一。 DHEA通過(guò)多種信號(hào)傳導(dǎo)途徑介導(dǎo)其作用,并通過(guò)轉(zhuǎn)化成雄激素和雌激素衍生物(例如,雄激素,雌激素,7α和7β DHEA (Prasterone),以及7α和7β表雄甾酮衍生物)通過(guò)其特異性受體起作用。

MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報(bào),我們不為任何個(gè)人用途提供產(chǎn)品和服務(wù)

DHEA Chemical Structure

DHEA Chemical Structure

CAS No. : 53-43-0

1.  客戶無(wú)需承擔(dān)相應(yīng)的運(yùn)輸費(fèi)用。

2.  同一機(jī)構(gòu)(單位)同一產(chǎn)品試用裝僅限申領(lǐng)一次,同一機(jī)構(gòu)(單位)一年內(nèi)

     可免費(fèi)申領(lǐng)三個(gè)不同產(chǎn)品的試用裝。

3.  試用裝只面向終端客戶。

規(guī)格 價(jià)格 是否有貨 數(shù)量
10 mM * 1 mL in DMSO ¥550
In-stock
100 mg ¥500
In-stock
250 mg ¥1000
In-stock
500 mg ¥1600
In-stock
1 g   詢價(jià)  
5 g   詢價(jià)  

* Please select Quantity before adding items.

Customer Review

Other Forms of DHEA:

MCE 顧客使用本產(chǎn)品發(fā)表的 26 篇科研文獻(xiàn)

  • 生物活性

  • 實(shí)驗(yàn)參考方法

  • 純度 & 產(chǎn)品資料

  • 參考文獻(xiàn)

生物活性

DHEA (Prasterone) is one of the most abundant steroid hormones. DHEA (Prasterone) mediates its action via multiple signaling pathways involving specific membrane receptors and via transformation into androgen and estrogen derivatives (e.g., androgens, estrogens, 7α and 7β DHEA, and 7α and 7β epiandrosterone derivatives) acting through their specific receptors.

IC50 & Target

Human Endogenous Metabolite

 

細(xì)胞效力
(Cellular Effect)
Cell Line Type Value Description References
A-431 IC50
> 50 μM
Compound: DHEA
Cytotoxic activity against human A431 cells after 24 hrs by MTT assay
Cytotoxic activity against human A431 cells after 24 hrs by MTT assay
[PMID: 25456391]
A-431 IC50
> 50 μM
Compound: DHEA
Cytotoxic activity against human A431 cells after 48 hrs by MTT assay
Cytotoxic activity against human A431 cells after 48 hrs by MTT assay
[PMID: 25456391]
A549 IC50
> 20 μM
Compound: c1
Antiproliferative activity against human A549 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
Antiproliferative activity against human A549 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
[PMID: 30822712]
A549 IC50
47.8 μM
Compound: DHEA
Cytotoxic activity against human A549 cells after 24 hrs by MTT assay
Cytotoxic activity against human A549 cells after 24 hrs by MTT assay
[PMID: 25456391]
A549 IC50
47.8 μM
Compound: DHEA
Cytotoxic activity against human A549 cells after 48 hrs by MTT assay
Cytotoxic activity against human A549 cells after 48 hrs by MTT assay
[PMID: 25456391]
CHO EC50
3.33 μM
Compound: 49
Agonist activity at human TGR5 expressed in CHO cells by luciferase assay
Agonist activity at human TGR5 expressed in CHO cells by luciferase assay
[PMID: 18307294]
DU-145 IC50
> 50 μM
Compound: DHEA
Antiproliferative activity against human DU145 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
Antiproliferative activity against human DU145 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
[PMID: 26866967]
HCT-116 IC50
> 50 μM
Compound: DHEA
Antiproliferative activity against human HCT116 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
Antiproliferative activity against human HCT116 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
[PMID: 26866967]
HEK293 EC50
> 10 μM
Compound: 19
Binding affinity to FLAG/tGFP-tagged NPC1 I1061T mutant (unknown origin) expressed in HEK293 cells assessed as localization after 24 hrs by fluorescence microscopy
Binding affinity to FLAG/tGFP-tagged NPC1 I1061T mutant (unknown origin) expressed in HEK293 cells assessed as localization after 24 hrs by fluorescence microscopy
[PMID: 24928400]
HEK-293T IC50
24.9 μM
Compound: 1, DHEA, dehydroepiandrosterone
Inhibition of G6PD in HEK293T cells assessed as accumulation of 6-phosphogluconate after 5 hrs by LC-MS/MS analysis using 6-aminonicotinamide
Inhibition of G6PD in HEK293T cells assessed as accumulation of 6-phosphogluconate after 5 hrs by LC-MS/MS analysis using 6-aminonicotinamide
[PMID: 22506561]
HeLa IC50
> 50 μM
Compound: DHEA
Cytotoxic activity against human HeLa cells after 24 hrs by MTT assay
Cytotoxic activity against human HeLa cells after 24 hrs by MTT assay
[PMID: 25456391]
HeLa IC50
> 50 μM
Compound: DHEA
Cytotoxic activity against human HeLa cells after 48 hrs by MTT assay
Cytotoxic activity against human HeLa cells after 48 hrs by MTT assay
[PMID: 25456391]
HepG2 IC50
> 50 μM
Compound: DHEA
Cytotoxic activity against human HepG2 cells after 24 hrs by MTT assay
Cytotoxic activity against human HepG2 cells after 24 hrs by MTT assay
[PMID: 25456391]
HepG2 IC50
> 50 μM
Compound: DHEA
Cytotoxic activity against human HepG2 cells after 48 hrs by MTT assay
Cytotoxic activity against human HepG2 cells after 48 hrs by MTT assay
[PMID: 25456391]
HL-60 IC50
> 20 μM
Compound: c1
Antiproliferative activity against human HL60 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
Antiproliferative activity against human HL60 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
[PMID: 30822712]
HL-60 IC50
> 50 μM
Compound: DHEA
Antiproliferative activity against human HL60 cells assessed as reduction in cell viability after 96 hrs by MTS assay
Antiproliferative activity against human HL60 cells assessed as reduction in cell viability after 96 hrs by MTS assay
[PMID: 26866967]
HT-29 IC50
> 50 μM
Compound: DHEA
Cytotoxic activity against human HT-29 cells after 24 hrs by MTT assay
Cytotoxic activity against human HT-29 cells after 24 hrs by MTT assay
[PMID: 25456391]
HT-29 IC50
> 50 μM
Compound: DHEA
Cytotoxic activity against human HT-29 cells after 48 hrs by MTT assay
Cytotoxic activity against human HT-29 cells after 48 hrs by MTT assay
[PMID: 25456391]
HT-29 IC50
> 50 μM
Compound: DHEA
Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
[PMID: 26866967]
J774.2 CC50
198.17 μM
Compound: 1a; DHEA
Cytotoxicity against mouse J774.2 cells assessed as reduction in cell viability measured after 48 hrs by resazurin dye based assay
Cytotoxicity against mouse J774.2 cells assessed as reduction in cell viability measured after 48 hrs by resazurin dye based assay
[PMID: 34571489]
Jurkat IC50
46.5 μM
Compound: DHEA
Antiproliferative activity against human Jurkat cells assessed as reduction in cell viability after 96 hrs by MTS assay
Antiproliferative activity against human Jurkat cells assessed as reduction in cell viability after 96 hrs by MTS assay
[PMID: 26866967]
LNCaP IC50
> 50 μM
Compound: DHEA
Cytotoxic activity against human LNCAP cells after 24 hrs by MTT assay
Cytotoxic activity against human LNCAP cells after 24 hrs by MTT assay
[PMID: 25456391]
LNCaP IC50
> 50 μM
Compound: DHEA
Cytotoxic activity against human LNCAP cells after 48 hrs by MTT assay
Cytotoxic activity against human LNCAP cells after 48 hrs by MTT assay
[PMID: 25456391]
LNCaP IC50
> 50 μM
Compound: DHEA
Antiproliferative activity against human LNCAP cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
Antiproliferative activity against human LNCAP cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
[PMID: 26866967]
MCF7 IC50
> 20 μM
Compound: c1
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
[PMID: 30822712]
MCF7 IC50
> 200 μM
Compound: DHEA
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
[PMID: 23880359]
MCF7 IC50
> 50 μM
Compound: DHEA
Cytotoxic activity against human MCF7 cells after 24 hrs by MTT assay
Cytotoxic activity against human MCF7 cells after 24 hrs by MTT assay
[PMID: 25456391]
MCF7 IC50
> 50 μM
Compound: DHEA
Cytotoxic activity against human MCF7 cells after 48 hrs by MTT assay
Cytotoxic activity against human MCF7 cells after 48 hrs by MTT assay
[PMID: 25456391]
MCF7 IC50
> 50 μM
Compound: DHEA
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
[PMID: 26866967]
MDA-MB-231 IC50
> 50 μM
Compound: DHEA
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
[PMID: 26866967]
PC-12 IC50
0.29 nM
Compound: DHEA
Neuroprotective activity in rat PC12 cells assessed as inhibition of serum deprivation-induced apoptosis after 24 hrs by APO Percentage apoptosis assay
Neuroprotective activity in rat PC12 cells assessed as inhibition of serum deprivation-induced apoptosis after 24 hrs by APO Percentage apoptosis assay
[PMID: 19845386]
PC-12 IC50
1.65 nM
Compound: DHEA
Displacement of [3H]DHEA from DHEA-binding site in rat PC12 cell membranes by gamma-scintillation counting
Displacement of [3H]DHEA from DHEA-binding site in rat PC12 cell membranes by gamma-scintillation counting
[PMID: 19845386]
SMMC-7721 IC50
> 20 μM
Compound: c1
Antiproliferative activity against human SMMC7721 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
Antiproliferative activity against human SMMC7721 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
[PMID: 30822712]
SW480 IC50
> 20 μM
Compound: c1
Antiproliferative activity against human SW480 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
Antiproliferative activity against human SW480 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
[PMID: 30822712]
T47D IC50
2.55 μM
Compound: DHEA
Antiproliferative activity against human T47D cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
Antiproliferative activity against human T47D cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
[PMID: 26866967]
體外研究
(In Vitro)

DHEA (Prasterone) is an effective antiapoptotic factor, reversing the serum deprivation-induced apoptosis in prostate cancer cells (DU145 and LNCaP cell lines) as well as in colon cancer cells (Caco2 cell line). DHEA (Prasterone) significantly reduces serum deprivation-induced apoptosis in all 3 cancer cell types, quantitated with the APOPercentage assay (apoptosis is reduced from 0.587±0.053 to 0.142±0.0016 or 0.059±0.002 after treatment for 12 hours with DHEA or NGF, respectively; n=3, P<0.01), and by flow cytometry analysis (FACS) for DU145 cells. The antiapoptotic effect of DHEA is dose dependent with an EC50 at nanomolar concentrations (EC50: 11.2±3.6 nM and 12.4±2.2 nM in DU145 and Caco2 cells, respectively)[1]. DHEA (Prasterone) is the principal sex steroid precursor in humans and can be converted directly to androgens. DHEA (Prasterone) (≥1 μM) causes a dose-dependent inhibition of Chub-S7 proliferation, as assessed by thymidine incorporation assays. DHEA (Prasterone) treatment inhibits expression of the key glucocorticoid-regulating genes H6PDH (≥100 nM) and HSD11B1 (≥1 μM) in differentiating preadipocytes in a dose-dependent manner. In keeping with this finding, DHEA (Prasterone) treatment (≥1 μM) results in a marked reduction in 11β-HSD1 oxoreductase activity (≥1 μM) and a concurrent increase in dehydrogenase activity at the highest DHEA dose used (25 μM DHEA) in differentiated adipocytes[2].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

體內(nèi)研究
(In Vivo)

DHEA (Prasterone) in the diet (0.45 % w/w) of male B6 mice (groups of five mice) treated for 8 weeks led to significant decreases in body temperature compared with mice fed the control AIN-76A diet. A similar comparison indicated that control and pair-fed mice are also significantly different. Animals fed DHEA (Prasterone) have significantly lower temperatures than mice fed the control diet 26/29 times tested; mice pair fed to those on the DHEA (Prasterone) diet are less affected, with 8/29 values significantly lower than in mice fed AIN-76A ad libitum. The temperatures of mice fed DHEA (Prasterone) or pair fed to DHEA (Prasterone) are significantly different 21/29 times tested. Body weights are significantly greater in mice fed the control diet than in mice fed DHEA or pair fed to DHEA (Prasterone). Food intake (grams per day) from cages are averaged for each week (n=7), except for Week 9 (n=3). The amount of food intake is significantly decreased in mice fed DHEA (Prasterone). By design, mice pair fed to DHEA (Prasterone) ate about the same amount. Thus, it appears that DHEA (Prasterone) reduces body temperature by food restriction and by a separate mechanism[3].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

分子量

288.42

Formula

C19H28O2

CAS 號(hào)
性狀

固體

顏色

White to off-white

中文名稱(chēng)

脫氫表雄酮;去氫表雄酮;脫氫表雄甾酮;脫氫異雄酮;反式-脫氫異雄甾酮;反式-脫氫雄甾酮;脫氫表雄至素酮

結(jié)構(gòu)分類(lèi)
初始來(lái)源
運(yùn)輸條件

Room temperature in continental US; may vary elsewhere.

儲(chǔ)存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 2 years
-20°C 1 year
溶解性數(shù)據(jù)
細(xì)胞實(shí)驗(yàn): 

DMSO 中的溶解度 : 50 mg/mL (173.36 mM; 超聲助溶; 吸濕的 DMSO 對(duì)產(chǎn)品的溶解度有顯著影響,請(qǐng)使用新開(kāi)封的 DMSO)

Ethanol 中的溶解度 : 40 mg/mL (138.69 mM; 超聲助溶 (<60°C))

H2O 中的溶解度 : < 0.1 mg/mL (insoluble)

配制儲(chǔ)備液
濃度 溶劑體積 質(zhì)量 1 mg 5 mg 10 mg
1 mM 3.4672 mL 17.3358 mL 34.6717 mL
5 mM 0.6934 mL 3.4672 mL 6.9343 mL
查看完整儲(chǔ)備液配制表

* 請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲(chǔ)備液;一旦配成溶液,請(qǐng)分裝保存,避免反復(fù)凍融造成的產(chǎn)品失效。
儲(chǔ)備液的保存方式和期限:-80°C, 2 years; -20°C, 1 year。-80°C儲(chǔ)存時(shí),請(qǐng)?jiān)?年內(nèi)使用, -20°C儲(chǔ)存時(shí),請(qǐng)?jiān)?年內(nèi)使用。

  • 摩爾計(jì)算器

  • 稀釋計(jì)算器

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

質(zhì)量
=
濃度
×
體積
×
分子量 *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

濃度 (start)

C1

×
體積 (start)

V1

=
濃度 (final)

C2

×
體積 (final)

V2

動(dòng)物實(shí)驗(yàn):

請(qǐng)根據(jù)您的 實(shí)驗(yàn)動(dòng)物和給藥方式 選擇適當(dāng)?shù)娜芙夥桨浮?

以下溶解方案都請(qǐng)先按照 In Vitro 方式配制澄清的儲(chǔ)備液,再依次添加助溶劑:
——為保證實(shí)驗(yàn)結(jié)果的可靠性,澄清的儲(chǔ)備液可以根據(jù)儲(chǔ)存條件,適當(dāng)保存;體內(nèi)實(shí)驗(yàn)的工作液,建議您現(xiàn)用現(xiàn)配,當(dāng)天使用;
以下溶劑前顯示的百分比是指該溶劑在您配制終溶液中的體積占比;如在配制過(guò)程中出現(xiàn)沉淀、析出現(xiàn)象,可以通過(guò)加熱和/或超聲的方式助溶

  • 方案 一

    請(qǐng)依序添加每種溶劑: 10% DMSO    90% Corn Oil

    Solubility: ≥ 2.5 mg/mL (8.67 mM); 澄清溶液

    此方案可獲得 ≥ 2.5 mg/mL(飽和度未知)的澄清溶液,此方案實(shí)驗(yàn)周期在半個(gè)月以上的動(dòng)物實(shí)驗(yàn)酌情使用。

    1 mL 工作液為例,取 100 μL 25.0 mg/mL 的澄清 DMSO 儲(chǔ)備液加到 900 μL玉米油中,混合均勻。

  • 方案 二

    請(qǐng)依序添加每種溶劑: 10% EtOH    90% (20% SBE-β-CD in Saline)

    Solubility: ≥ 2.5 mg/mL (8.67 mM); 澄清溶液

    此方案可獲得 ≥ 2.5 mg/mL(飽和度未知)的澄清溶液。

    1 mL 工作液為例,取 100 μL 25.0 mg/mL 的澄清 EtOH 儲(chǔ)備液加到 900 μL 20% 的 SBE-β-CD 生理鹽水水溶液 中,混合均勻。

    2 g SBE-β-CD(磺丁基醚 β-環(huán)糊精)粉末定容于 10 mL 的生理鹽水中,完全溶解至澄清透明。

以下溶解方案,請(qǐng)直接配制工作液。建議現(xiàn)用現(xiàn)配,在短期內(nèi)盡快用完。 以下溶劑前顯示的百分比是指該溶劑在您配制終溶液中的體積占比; 如在配制過(guò)程中出現(xiàn)沉淀、析出現(xiàn)象,可以通過(guò)加熱和/或超聲的方式助溶。

  • 方案 一

    請(qǐng)依序添加每種溶劑: Corn Oil

    Solubility: 10 mg/mL (34.67 mM); 澄清溶液; 超聲助溶

  • 方案 二

    請(qǐng)依序添加每種溶劑: 15% Cremophor EL    85% Saline

    Solubility: 25 mg/mL (86.68 mM); 懸濁液; 超聲助溶

動(dòng)物溶解方案計(jì)算器
請(qǐng)輸入動(dòng)物實(shí)驗(yàn)的基本信息:

給藥劑量

mg/kg

動(dòng)物的平均體重

g

每只動(dòng)物的給藥體積

μL

動(dòng)物數(shù)量

由于實(shí)驗(yàn)過(guò)程有損耗,建議您多配一只動(dòng)物的量
請(qǐng)輸入您的動(dòng)物體內(nèi)配方組成:
%
DMSO +
+
%
Tween-80 +
%
Saline
如果您的動(dòng)物是免疫缺陷鼠或者體弱鼠,建議 DMSO 中的在最后工作液體系中的占比盡量不超過(guò) 2%。
方案所需 助溶劑 包括:DMSO, ,均可在 MCE 網(wǎng)站選購(gòu)。 ,Tween 80,均可在 MCE 網(wǎng)站選購(gòu)。
計(jì)算結(jié)果
工作液所需濃度 : mg/mL
儲(chǔ)備液配制方法 : mg 藥物溶于 μL  DMSO(母液濃度為 mg/mL)。
您所需的儲(chǔ)備液濃度超過(guò)該產(chǎn)品的實(shí)測(cè)溶解度,以下方案僅供參考,如有需要,請(qǐng)與 MCE 中國(guó)技術(shù)支持聯(lián)系。
動(dòng)物實(shí)驗(yàn)體內(nèi)工作液的配制方法 : 取 μL DMSO 儲(chǔ)備液,加入 μL 。 μL ,混合均勻至澄清,再加 μL Tween 80,混合均勻至澄清,再加 μL 生理鹽水。
連續(xù)給藥周期超過(guò)半月以上,請(qǐng)謹(jǐn)慎選擇該方案。
請(qǐng)確保第一步儲(chǔ)備液溶解至澄清狀態(tài),從左到右依次添加助溶劑。您可采用超聲加熱 (超聲清洗儀,建議頻次 20-40 kHz),渦旋吹打等方式輔助溶解。
純度 & 產(chǎn)品資料

純度: 99.93%

參考文獻(xiàn)
Cell Assay
[2]

Chub-S7 preadipocytes and human primary preadipocytes are seeded into a 24-well plate at densities 1×105 and 2.5×105 respectively. Following overnight culture, medium is supplemented with DHEA, androstenediol, or DHEA (Prasterone) (0-100 μM). Following 24-, 48-, or 72 h incubation, cell proliferation is assessed by incubation with radiolabeled thymidine (0.2 μCi/well) for the final 6 h of culture. Proteins are precipitated with TCA, and cells are scraped in NaOH. The respective content of radiolabeled nuclear material in the resulting lysates is analyzed by scintillation counting[2].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Administration
[3]

Mice[3]
Mice are fed Purina Lab Chow until the start of experiments (Day 0). Groups of five mice are then fed pelleted AIN-76A diet containing either no additive or DHEA (0.45% w/w) between 0900 and 1000 hr. Diets are stored at 4°C for no longer than six months to maintain optimal activity. Mice are given the diets ad libitum, except for mice that are pair fed to mice treated with DHEA (Prasterone). The amounts of AIN-76A diet the pair-fed mice received are determined by the weight of food consumed by the DHEA-fed mice on a daily basis. Body weights (grams) are measured at different time points starting at Day 1 and ending at Day 59. Daily food intakes (grams per day) are determined by weighing the food consumed per cage of five mice. The mean±SEM values are calculated for weeks 1 to 8 (n=7); week 9 had only 3 days.

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

參考文獻(xiàn)

完整儲(chǔ)備液配制表

* 請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲(chǔ)備液;一旦配成溶液,請(qǐng)分裝保存,避免反復(fù)凍融造成的產(chǎn)品失效
儲(chǔ)備液的保存方式和期限:-80°C, 2 years; -20°C, 1 year。-80°C儲(chǔ)存時(shí),請(qǐng)?jiān)?年內(nèi)使用, -20°C儲(chǔ)存時(shí),請(qǐng)?jiān)?年內(nèi)使用。

可選溶劑 濃度 溶劑體積 質(zhì)量 1 mg 5 mg 10 mg 25 mg
Ethanol / DMSO 1 mM 3.4672 mL 17.3358 mL 34.6717 mL 86.6791 mL
5 mM 0.6934 mL 3.4672 mL 6.9343 mL 17.3358 mL
10 mM 0.3467 mL 1.7336 mL 3.4672 mL 8.6679 mL
15 mM 0.2311 mL 1.1557 mL 2.3114 mL 5.7786 mL
20 mM 0.1734 mL 0.8668 mL 1.7336 mL 4.3340 mL
25 mM 0.1387 mL 0.6934 mL 1.3869 mL 3.4672 mL
30 mM 0.1156 mL 0.5779 mL 1.1557 mL 2.8893 mL
40 mM 0.0867 mL 0.4334 mL 0.8668 mL 2.1670 mL
50 mM 0.0693 mL 0.3467 mL 0.6934 mL 1.7336 mL
60 mM 0.0578 mL 0.2889 mL 0.5779 mL 1.4447 mL
80 mM 0.0433 mL 0.2167 mL 0.4334 mL 1.0835 mL
100 mM 0.0347 mL 0.1734 mL 0.3467 mL 0.8668 mL
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的產(chǎn)品:

Your information is safe with us. * Required Fields.

   產(chǎn)品名稱(chēng):

 

* 需求量:

* 客戶姓名:

 

* Email:

* 電話:

 

* 公司或機(jī)構(gòu)名稱(chēng):

   留言給我們:

Bulk Inquiry

Inquiry Information

產(chǎn)品名稱(chēng):
DHEA
目錄號(hào):
HY-14650
需求量: